Texas Instruments Incorporated v. Greenthread, LLC

IPR2024-00771

Texas Instruments Incorporated filed a petition challenging U.S. Patent No. 8,421,195 regarding CMOS fabrication/doping profiles. The petitioner asserts that the claims are anticipated or obvious based on numerous prior art references including Onoda and Payne. This challenges the patent's validity in semiconductor device technology.

Jurisdiction
US PTAB
Case Number
IPR2024-00771
Filing Date
4 October 2024
Outcome
null

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Texas Instruments Incorporated vs Greenthread, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-01133

BOE Technology Group Co., LTDvsOptronic Sciences, LLC

The PTAB issued a Final Written Decision finding all 13 claims unpatentable by preponderance of the evidence. The Board found that the challenged claims were obvious over various combinations of prior art references, including Weaver combined with Lee ’053 and Song.

patentIPR2024-00890

Abbott Diabetes Care Inc. et al.vsDexCom, Inc.

Abbott Diabetes Care Inc. successfully petitioned to institute IPR against DexCom, Inc.'s glucose monitoring patent (11020031). The Board found sufficient evidence for trial on 22 claims based on anticipation and obviousness over prior art from Zhang and Shin.

patentIPR2025-00840

Docker Inc.vsIntellectual Ventures II LLC

The USPTO Board denied the institution of IPR2025-00840, favoring Intellectual Ventures II LLC's request for discretionary denial. The decision cited parallel district court and IPR proceedings as reasons to conserve resources.

patentIPR2024-00841

Abbott Diabetes Care Inc. et al.vsDexCom, Inc.

Abbott Diabetes Care Inc.'s IPR challenge against DexCom's glucose monitoring patent was instituted by the PTAB. The Board found a reasonable likelihood of success on anticipation and obviousness grounds over prior art reference Gross, despite acknowledging examination complexity. This decision advances Abbott's efforts to invalidate key claims in the medical device space.

patentIPR2024-00489

Visa, Inc.vsCortex MCP, Inc.

The PTAB found most claims of the '859 patent unpatentable based on obviousness (103). The Board adopted Petitioner's view regarding the level of ordinary skill in the art and construed key terms like 'OVER file.' Claims 2, 10, 19, and 21 survived the challenge.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call